Published in J Public Health Med on December 01, 2001
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med (2013) 3.24
Consequences of false-positive screening mammograms. JAMA Intern Med (2014) 1.81
What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules. Chest (2013) 1.79
Interventions to improve follow-up of abnormal findings in cancer screening. Cancer (2004) 1.41
Guidelines from the European Society of Breast Imaging for diagnostic interventional breast procedures. Eur Radiol (2007) 1.32
Psychologic stress, reduced NK cell activity, and cytokine dysregulation in women experiencing diagnostic breast biopsy. Psychoneuroendocrinology (2006) 1.17
Psychological costs of inadequate cervical smear test results. Br J Cancer (2004) 1.15
Consequences of Screening in Breast Cancer (COS-BC): development of a questionnaire. Scand J Prim Health Care (2008) 1.06
Measuring the psychosocial consequences of screening. Health Qual Life Outcomes (2007) 1.03
Older women's experience with a benign breast biopsy—a mixed methods study. J Gen Intern Med (2014) 1.00
'The thing is not knowing': patients' perspectives on surveillance of an indeterminate pulmonary nodule. Health Expect (2012) 0.94
Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial. BMJ Open (2012) 0.91
A model of the influence of false-positive mammography screening results on subsequent screening. Health Psychol Rev (2010) 0.89
Diagnostic invasiveness and psychosocial consequences of false-positive mammography. Ann Fam Med (2015) 0.85
Clinical, demographic, and situational factors linked to distress associated with benign breast biopsy. J Psychosoc Oncol (2011) 0.85
False-positive results in the randomized controlled trial of mammographic screening from age 40 ("Age" trial). Cancer Epidemiol Biomarkers Prev (2010) 0.83
FIT false-positives in colorectal cancer screening experience psychological distress up to 6 weeks after colonoscopy. Support Care Cancer (2013) 0.82
Psychosocial Factors Associated With Withdrawal From the United Kingdom Collaborative Trial of Ovarian Cancer Screening After 1 Episode of Repeat Screening. Int J Gynecol Cancer (2015) 0.82
Non-operative diagnosis--effect on repeat-operation rates in the UK breast screening programme. Eur Radiol (2008) 0.79
Online support: Impact on anxiety in women who experience an abnormal screening mammogram. Breast (2014) 0.78
Patients' Knowledge, Beliefs, and Distress Associated with Detection and Evaluation of Incidental Pulmonary Nodules for Cancer: Results from a Multicenter Survey. J Thorac Oncol (2016) 0.77
Psychological impact of breast cancer screening in Japan. Int J Clin Oncol (2015) 0.77
False positive mammograms in Europe: do they affect reattendance? Breast Cancer Res Treat (2010) 0.77
Discrepant screening mammography assessments at blinded and non-blinded double reading: impact of arbitration by a third reader on screening outcome. Eur Radiol (2015) 0.75
Recall Rate Reduction with Tomosynthesis During Baseline Screening Examinations: An Assessment From a Prospective Trial. Acad Radiol (2015) 0.75
Waiting time and the psychosocial consequences of false-positive mammography: cohort study. J Negat Results Biomed (2015) 0.75
Association between Breast Parenchymal Complexity and False-Positive Recall From Digital Mammography Versus Breast Tomosynthesis: Preliminary Investigation in the ACRIN PA 4006 Trial. Acad Radiol (2016) 0.75
MRI screening for breast cancer in women at high risk; is the Australian breast MRI screening access program addressing the needs of women at high risk of breast cancer? J Med Radiat Sci (2015) 0.75
Response costs of mammography adherence: Iranian women's perceptions. Health Promot Perspect (2016) 0.75
Trends in breast biopsies for abnormalities detected at screening mammography: a population-based study in the Netherlands. Br J Cancer (2013) 0.75
Impact of a False-Positive Screening Mammogram on Subsequent Screening Behavior and Stage at Breast Cancer Diagnosis. Cancer Epidemiol Biomarkers Prev (2017) 0.75
Public awareness of cancer in Britain: a population-based survey of adults. Br J Cancer (2009) 3.81
Computer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated cases. BMJ (2000) 3.12
Gaining informed consent for screening. Is difficult--but many misconceptions need to be undone. BMJ (1999) 3.10
Development of a measurement tool to assess public awareness of cancer. Br J Cancer (2009) 2.79
The psychological impact of mammographic screening. A systematic review. Psychooncology (2005) 2.33
The 'new genetics' and primary care: GPs' views on their role and their educational needs. Fam Pract (1999) 2.28
Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment. J Public Health Med (1998) 2.06
Awareness of cancer symptoms and anticipated help seeking among ethnic minority groups in England. Br J Cancer (2009) 1.62
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Breast screening: adverse psychological consequences one month after placing women on early recall because of a diagnostic uncertainty. A multicentre study. J Med Screen (1997) 1.40
Effect on attendance at breast cancer screening of adding a self administered questionnaire to the usual invitation to breast screening in southern England. J Epidemiol Community Health (1998) 1.33
Identifying symptoms of ovarian cancer: a qualitative and quantitative study. BJOG (2008) 1.33
Recalling women for further investigation of breast screening: women's experiences at the clinic and afterwards. J Public Health Med (1997) 1.30
Evaluation of the impact of two educational interventions on GP management of familial breast/ovarian cancer cases: a cluster randomised controlled trial. Br J Gen Pract (2001) 1.20
Improving attendance for breast screening among recent non-attenders: a randomised controlled trial of two interventions in primary care. J Med Screen (2001) 1.07
A study of GP referrals to a family cancer clinic for breast/ovarian cancer. Fam Pract (2001) 1.07
The impact of screening on future health-promoting behaviours and health beliefs: a systematic review. Health Technol Assess (2003) 1.04
Fractionation of nuclei from brain by zonal centrifugation and a study of the ribonucleic acid polymerase activity in the various classes of nuclei. Biochem J (1972) 1.02
Factors associated with breast cancer-specific distress in younger women participating in a family history mammography screening programme. Psychooncology (2008) 0.92
Cluster randomised controlled trial comparing the effectiveness and cost-effectiveness of two primary care interventions aimed at improving attendance for breast screening. J Med Screen (2001) 0.88
Compliance in screening programmes .... and in breast screening programme. BMJ (1994) 0.87
Workgroup IV: public education. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002). Ann Oncol (2005) 0.84
Education improves general practitioner (GP) management of familial breast/ovarian cancer: findings from a cluster randomised controlled trial. J Med Genet (2002) 0.84
New developments in genetics-knowledge, attitudes and information needs of practice nurses. Fam Pract (2001) 0.84
Revision of "NHS breast screening: the facts": an evaluation. J Med Screen (1995) 0.82
Early rescreen/recall in the UK National Health Service breast screening programme: epidemiological data. J Med Screen (1998) 0.81
Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer. J Epidemiol Biostat (2001) 0.80
Cervical screening result communication: a focus-group investigation of English women's experiences and needs. Qual Saf Health Care (2008) 0.79
Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme. Psychooncology (2008) 0.78
Mammographic screening for young women with a family history of breast cancer: knowledge and views of those at risk. Br J Cancer (2008) 0.78
Quality assurance in screening programmes. Br Med Bull (1998) 0.77
The 'treatment of choice': breast cancer surgery 1860-1985. Soc Soc Hist Med Bull (Lond) (1985) 0.77
Diagnosed with breast cancer while on a family history screening programme: an exploratory qualitative study. Eur J Cancer Care (Engl) (2008) 0.77
The development of a new site-specific measure of quality of life for breast problems: the Cardiff breast scales. Qual Life Res (2002) 0.76
The synthesis of ribonucleic acid in vivo in the nuclei of rat brain fractionated by zonal centrifugation. Biochem J (1973) 0.76
Eugenics and the Registrar General. Br Med J (Clin Res Ed) (1985) 0.75
The potential and pitfalls for developing guidelines in oncology. Ann Oncol (2001) 0.75
The politics of cancer research: Walter Morley Fletcher and the origins of the British Empire cancer campaign. Soc Soc Hist Med Bull (Lond) (1985) 0.75
Watching for change: being breast aware. Nurs Stand (1995) 0.75